Home / Medicines / Clinical trial on pharmaceuticals / Related information / Opinion of SÚKL's Department of Clinical Trials...

Opinion of SÚKL's Department of Clinical Trials on Medicinal Products on Ongoing Clinical Trials and To-Be-Commenced Clinical Trials in Light of the COVID-19 Epidemiological Situation of 22 December 2020

fully superseding opinions of 06 November 2020  

pdf.pngOpinion of SÚKL - 22. 12. 2020- eng final.pdf

Please see the highlighted changes in the PDF document:
pdf.pngOpinion of SÚKL - 22. 12. 2020- eng with revision.pdf

The new COVID-19 terms:

pdf.pngthe new COVID-19 terms_cze
pdf.pngthe new COVID-19 terms_eng

Updated Guidance version 3:

Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic released by EMA and GCP IWG, version 3, dated 28.4.2020

 

Department of Clinical Trials on Medicinal Products

Date: 23 December 2020

Archive: 

pdf.png16.03.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 20.03.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 03.04.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 06.04.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 23.04.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 14.05.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 25.06.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 01.07.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 28.08.2020 Opinion of SÚKL´s OKH on ongoing CT

pdf.png 06.11.2020 Opinion of SÚKL´s OKH on ongoing CT

 

2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@sukl_cz.

Web portal supplier - QCM, s.r.o.